Consumer Health Diabetes
Yunovia Gains MFDS Clearance for Phase 1 MAD Study of Oral GLP-1 Agonist for Diabetes and Obesity
Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has clea...
August 28, 2024 | News
FDA Expands Approval of Insulet SmartAdjust Technology to Include Type 2 Diabetes Management
U.S. Food and Drug Administration expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycemic controller previously...
August 27, 2024 | News
AiViva Biopharma Completes Enrollment in Phase 1 Trial of AIV007 for Wet AMD and DME
AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient in a Phase 1 tria...
August 26, 2024 | News
Sanyou Bio and JiAnTeBo Forge Strategic Partnership to Innovate Metabolic Disease Therapies
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...
August 08, 2024 | News
MTD Expands into India and China with Ypsomed Acquisition
Medical Technology and Devices (MTD) is pleased to announce the successful closing of the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring...
August 05, 2024 | News
Eluminex Biosciences Administers First Dose of EB-105 to Diabetic Macular Edema Patient in US
Eluminex Biosciences announced that their tri-specific fusion antibody drug, EB-105, has administered its first dose to a diabetic macular edema patient in...
July 29, 2024 | News
CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Calliditas Therapeutics and Viatris Initiate Phase III Trial for IgA Nephropathy in Japan
Calliditas Therapeutics AB announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in&...
July 05, 2024 | News
Endogenex Secures $88 Million in Oversubscribed Series C Financing to Advance Diabetes Treatment
Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed an oversubs...
June 26, 2024 | News
Chinese Researchers Demonstrate Significant Cardiovascular Benefits of Early Insulin Therapy in Diabetes
Recently, Professor Jianping Weng of the University of Science and Technology of China (USTC) and President of Anhui Medical University and ...
June 20, 2024 | Report
Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea
Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...
May 07, 2024 | News
Cynata Therapeutics Completes Patient Enrolment for Diabetic Foot Ulcer Trial
Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics,&n...
April 08, 2024 | News
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U...
January 31, 2024 | News
IDF and Sanofi Partner to Boost Diabetes Response in 40 Nations
The International Diabetes Federation (IDF), in collaboration with Sanofi's Global Health Unit (GHU), is taking significant steps to improve...
January 16, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
